KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Treasury Shares (2016 - 2025)

Humana (HUM) has disclosed Treasury Shares for 16 consecutive years, with $14.5 billion as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares changed N/A to $14.5 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $14.5 billion, a N/A change, with the full-year FY2022 number at $12.2 billion, up 19.61% from a year prior.
  • Treasury Shares was $78.1 million for Q4 2025 at Humana, roughly flat from $78.4 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $78.4 million in Q2 2025 to a low of $1.2 million in Q2 2023.
  • A 4-year average of $67.8 million and a median of $73.7 million in 2023 define the central range for Treasury Shares.
  • Biggest YoY gain for Treasury Shares was 20.44% in 2021; the steepest drop was 2.47% in 2021.
  • Humana's Treasury Shares stood at $10.2 billion in 2021, then grew by 19.61% to $12.2 billion in 2022, then increased by 8.05% to $13.1 billion in 2023, then increased by 10.13% to $14.5 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Treasury Shares are $14.5 billion (Q3 2025), $14.5 billion (Q2 2025), and $14.4 billion (Q1 2025).